Solana 价格预测:市场复苏期间 SOL 价格暗示上涨 20%?

币界网Published on 2024-08-09Last updated on 2024-08-09

币界网报道:

本周,加密货币市场持续呈现上涨趋势,顶级代币在短时间内经历了大幅波动。然而,比特币价格上涨 7.23%,成功重新站上 6.1 万美元关口。

此外,Solana 的价格也表现出类似的强劲走势,突破了关键阻力位。随着市场波动性不断加大,现在是否是投资 SOL 以把握即将到来的加密货币牛市的好时机呢?

图片

SOL 代币价格记录看涨行动增加:

Solana 价格成功回踩了关键支撑位 127 美元,推动了本周的强劲反弹。此外,过去 24 小时内,Solana 价格上涨约 2%,交易量达到了 47.81 亿美元。

图片TradingView:SOL/USDT

值得注意的是,SOL 价格目前在关键支撑/阻力位 155 美元附近波动,过去几个小时内下跌了 4.17%。目前,SOL 的交易价格为 157.24 美元,流通供应量为 446,339,138 枚,市值达 731.44 亿美元,排名第五。它还需超过 10 亿美元才能超越币安的市值。

Solana 市场情绪:

简单移动平均线 (SMA) 在 1 日时间范围内显示出看涨的收敛,表明市场对 SOL 加密代币的购买压力正在增加。此外,MACD 指标的红色直方图持续缩小,表明看涨收敛的可能性很高。这些信号表明,SOL 在未来一段时间内前景乐观。

SOL 价格今年 8 月会回升至 200 美元吗?

如果市场能将 Solana 代币维持在 155 美元的支撑位上方,多头可能会重新获得势头,推动价格向 181.50 美元的阻力位迈进。成功维持这一水平将为 SOL 价格在未来几周内测试 200 美元的上限阻力位奠定基础。

相反,如果空头重新发力,Solana 可能会再次测试 155 美元的支撑位。如果多头在这一关键时刻未能重新掌控局面,SOL 价格可能会在本月跌至较低的支撑位 127 美元。

Trending Cryptos

Related Reads

Stock Price Doubles Within the Year, Plummets 20% After Resumption, Baolai Medical's 'Chip Backdoor Listing' Script Ends

On August 10, 2026, BPL (300246.SZ) resumed trading after a nearly week-long suspension and immediately fell by a 20% limit-down. This plunge was triggered by the termination of a planned controlling stake transfer, dashing earlier market speculation. In January 2026, Zhejiang Quwei Zhihe Partnership entered as a significant shareholder, sparking hopes. Investors speculated that its backer, Weigu Information—a specialized "little giant" company in high-reliability solid-state storage chips—might be seeking a backdoor listing through BPL. This "cross-industry restructuring" expectation fueled a strong rally, with BPL's stock price more than doubling in 2026 prior to the halt. However, the deal was called off on August 7, directly causing the sharp sell-off. Underlying BPL's vulnerability is its fundamentally weak business. The company, a medical device firm, is mired in losses, having reported three consecutive years of net losses totaling over 200 million yuan. Its core hemodialysis business is squeezed by government procurement price cuts, while growth in its patient monitor segment has stalled. Furthermore, BPL faces imminent debt pressure with convertible bonds worth approximately 218 million yuan due in September 2026, and its current stock price is far below the conversion price. The failed control transfer may represent a delayed release of negative news, but BPL's core challenges remain: reversing operational losses and addressing its urgent liquidity crisis.

marsbit1h ago

Stock Price Doubles Within the Year, Plummets 20% After Resumption, Baolai Medical's 'Chip Backdoor Listing' Script Ends

marsbit1h ago

Trading

Spot

Hot Articles

Discussions

Welcome to the HTX Community. Here, you can stay informed about the latest platform developments and gain access to professional market insights. Users' opinions on the price of SOL (SOL) are presented below.

活动图片